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ABSTRACT
Background: Epidemiologic studies suggest inverse associations
between consumption of egg, a major source of dietary cholesterol,
and stroke. However, the evidence of the relation remains limited,
especially among carriers of apolipoprotein E4 (apoE4), which
influences cholesterol metabolism.
Objective: The aim of this study was to investigate associations of
egg and cholesterol intakes with risk of stroke and with the major
stroke risk factor, blood pressure, in middle-aged and older men from
eastern Finland and whether apoE phenotype could modify these
associations.
Methods: A total of 1950 men aged 42–60 y in 1984–1989 were
included at the baseline examinations of the prospective population-
based Kuopio Ischaemic Heart Disease Risk Factor Study. Data on
apoE phenotype were available for 1015 men. Dietary intakes were
assessed with 4-d food records at baseline and incident stroke events
were assessed by record linkage to hospital discharge registries.
Cox proportional hazards regression analyses were used to estimate
associations with stroke risk. Associations with baseline blood
pressure were evaluated with ANCOVA.
Results: During the mean ± SD follow-up of 21.2 ± 7.2 y, there
were 217 incidences of any stroke: 166 of ischemic stroke and 55 of
hemorrhagic stroke. Comparing the highest egg intake quartile with
the lowest, the multivariable-adjusted HRs were 0.81 for total stroke
(95% CI: 0.54, 1.23; P-trend = 0.32), 0.84 for ischemic stroke (95%
CI: 0.53, 1.34; P-trend = 0.44), and 0.75 for hemorrhagic stroke
(95% CI: 0.32, 1.77; P-trend = 0.40). The respective HRs for the
highest cholesterol intake quartile compared with the lowest were
0.86 (95% CI: 0.57, 1.32; P-trend = 0.42), 0.74 (95% CI: 0.46, 1.20;
P-trend = 0.32), and 1.10 (95% CI: 0.45, 2.66; P-trend = 0.75).
Diastolic blood pressure was 1.6 mm Hg (P-trend = 0.04) lower in
the highest egg intake quartile compared with the lowest, but there
were no associations with systolic blood pressure or with cholesterol
intake. ApoE phenotype (32% had apoE4 phenotype) did not modify
the associations.
Conclusion: Neither egg nor cholesterol intakes were associated
with stroke risk in this cohort, regardless of apoE phenotype. This
trial was registered at www.clinicaltrials.gov as NCT03221127.
Am J Clin Nutr 2019;110:169–176.
Keywords: eggs, cholesterol, stroke, apolipoprotein e4, prospective
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Introduction
Stroke is one of the leading causes of global noncommunicable
disease mortality and disability (1, 2). Prevention strategies are
aimed toward reducing risk from modifiable factors, including
dietary habits (3). Dietary recommendations on egg consumption,
particularly yolk, have historically been restrictive because of the
high amount of cholesterol in egg (∼200 mg per medium-sized
egg).
Relatively few studies have investigated the associations of egg
or cholesterol intakes with risk of stroke, and especially with
different types of stroke. Recent meta-analyses controversially
indicate there to be either increased (4) or no association (5,
6) between cholesterol intake and stroke risk; however, egg
consumption has been associated with both slightly lower (7, 8)
and higher (4) risk of total stroke. In contrast, no associations
between consumption of up to ∼1 egg/d and risk of stroke were
found in most earlier meta-analyses (9, 10), with the exception
of one (9) reporting inverse associations with hemorrhagic
stroke.
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High blood pressure is a major risk factor for stroke (11), but
few studies have reported on the associations of egg or cholesterol
intakes with blood pressure. In 1 study, egg consumption was
associated with lower systolic and diastolic blood pressure (8),
whereas other studies found that cholesterol intake and systolic
blood pressure were positively associated (12, 13).
For the general population, dietary cholesterol has only a
modest effect on serum cholesterol concentrations (14). However,
the influence of dietary cholesterol on serum LDL cholesterol
concentrations is more pronounced among those with genetic
susceptibility, such as phenotypic apolipoprotein E (apoE) allele
4 (apoE4) (15). The prevalence of the apoE4 phenotype is
exceptionally common among Finns, with about one-third of
the Finnish population possessing ≥1 E4 allele (16). The apoE4
phenotype is associated with higher cardiovascular disease and
stroke risk (17, 18). We recently reported that higher egg or
cholesterol intakes were not associated with less favorable lipid
profiles or greater coronary artery disease (CAD) risk, even
among apoE4 carriers, among middle-aged and older eastern
Finnish men in the Kuopio Ischaemic Heart Disease Risk Factor
Study (KIHD) (19). However, there is no information on whether
apoE phenotype could modify the associations between egg or
cholesterol consumption and stroke risk.
Because of the limited evidence, we investigated the associa-
tions of egg and cholesterol intakes with the risk of incident stroke
and with baseline systolic and diastolic blood pressure in men
from the KIHD. As a secondary analysis, we elucidated whether
these associations differ between apoE4 phenotype carriers and
noncarriers within a subgroup of 1015 men.
Methods
Study population
The KIHD was designed to investigate risk factors for
cardiovascular disease and related outcomes in a population-
based sample of men from eastern Finland (20). The baseline
examinations were carried out in 1984–1989. All men who were
42, 48, 54, or 60 y old and living in the city of Kuopio and
surrounding rural communities during the baseline examinations
were invited to participate in the KIHD. Of the 3235 eligible
men, 2682men (82.9%) participated in the baseline examinations
in 2 cohorts. The first cohort consisted of 1166 54-y-old men,
enrolled in 1984–1986, and the second cohort included 1516 men
aged 42, 48, 54, or 60 y, enrolled in 1986–1989. The baseline
characteristics of the entire study population have been described
previously (21). The KIHD study protocol was approved by the
Research Ethics Committee of the University of Kuopio. All
subjects gave written informed consent for participation.
Subjects with history of stroke (n = 69) or CAD (n = 640) at
baseline, or with missing data on dietary intakes (n = 23), were
excluded, leaving 1950 men for the analyses of incident stroke
(Supplemental Figure 1). Data for systolic and diastolic blood
pressure were available for 99% of men (n = 1939) and data for
apoE phenotype for 52% of men (n = 1015).
Assessment of dietary intakes
The consumption of foods was assessed at baseline in 1984–
1989 with the use of a 4-d guided food record, 1 d of which was
a weekend day, by using household measures. A picture book
of common foods and dishes was used to help in the estimation
of portion sizes. The picture book contained 126 of the most
common foods and drinks that are consumed in Finland and, for
each food item, the participant could choose from 3–5 commonly
used portion sizes or describe the portion size in relation to
those in the book. To further improve accuracy, instructions were
given, and completed food records were checked by a nutritionist
together with the participant. Nutrient intakes were estimated
with the use of NUTRICA version 2.5 software (Social Insurance
Institution, Finland). The databank of the software is mainly
based on Finnish values for the nutrient compositions of foods.
Nutrient intakes were energy adjusted with the use of the residual
method (22). The egg-consumption variable represented total egg
consumption and included the intake of eggs in mixed dishes and
recipes.
Assessment of stroke
Incident strokes in 1984–1992 were observed through the
FINMONICA (Finnish Monitoring Trends and Determinants
in Cardiovascular Diseases) stroke register (23). Information
regarding the stroke incidence in 1993–2012 was collected
through computerized linkage to the National Hospital Discharge
Registry. Fatal stroke events were captured through computerized
linkage to Statistics Finland’s causes of death register. The
diagnosis of stroke was based on sudden onset of clinical signs
or local or global disturbance of cerebral function lasting ≥24 h
(except in the case of sudden death or if interrupted by surgical
intervention) with no apparent cause other than a vascular origin.
Each suspected stroke [International Classification of Diseases
(ICD)-9 codes 430–439 and ICD-10 codes I60–I68 and G45–
G46] was classified into the following: a definite stroke, no
stroke, or an unclassifiable stroke event. The FINMONICA stroke
register data were annually rechecked with the data obtained
from the computerized National Hospital Discharge Registry and
the cause of death register. Definite strokes and unclassifiable
events were included in the group of any stroke. Each definite
stroke was classified into an ischemic stroke (ICD-9 codes 433–
434; ICD-10 code I63) or a hemorrhagic stroke (ICD-9 codes
430–431; ICD-10 codes I60–I61). If the subject had multiple
nonfatal strokes during follow-up, the first stroke was considered
as the endpoint. In cases of suspected nonfatal stroke events,
computed tomography or MRI was performed in 90% of the
patients by 1993 and imaging reached 100% by 1997. All fatal
strokes were confirmed with autopsy. Every resident of Finland
has a unique personal identifier that is used in registers. There
were very few losses to follow-up from subjects who moved
abroad (n = 3).
Other measurements
Fasting venous blood samples were collected between 0800
and 1000 at the baseline examinations in 1984–1989. Subjects
were instructed to abstain from ingesting alcohol for 3 d and
from smoking and eating for 12 h before giving the sample.
Resting blood pressure was measured 6 times with a random-zero
mercury sphygmomanometer: 3 times in a supine position after
a rest of 5 min before each measurement, 1 time in a standing
position after a standing rest of 1 min, and 2 times in a sitting
position after 5 min rest before both measurements. The mean
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of each respective 6 values was used in the present analyses as
the systolic and diastolic blood pressure. Detailed descriptions
of the determination of serum lipids and lipoproteins (21) and
the assessments of patient medical history and medication use
(21), family history of diseases (21), smoking (21), alcohol intake
(21), and leisure-time physical activity (24) have been previously
published. Education in years and marital status were assessed
with the use of a self-administered questionnaire. BMI was
computed as kg/m2. The apoE phenotype was determined from
plasma with the use of isoelectric focusing and immunoblotting
techniques. Subjects who had the phenotype 3/4 or 4/4 were
included in the apoE4 group.
Statistical analysis
The univariate relations between egg and cholesterol intakes
and baseline characteristics were assessed with the use of means
and linear regression (for continuous variables) or chi-square
tests (for bivariate relations). Cox proportional hazards regression
models were used to estimate HRs for incident stroke in quartiles
or tertiles of baseline egg and cholesterol intakes. Tertiles were
used in the subgroup analyses stratified by the apoE4 phenotype
owing to the lower number of incident events. The associations
of egg and cholesterol intakes with systolic and diastolic blood
pressure at baseline were analyzed with the use of ANCOVA.
Two statistical models were used to investigate the associ-
ations. Model 1 included age (years), examination year, and
energy intake (kilocalories per day). The multivariable model
(model 2) included the model 1 variables and BMI; pack-years
of smoking (cigarette packs per day multiplied by years of
smoking); leisure-time physical activity (kilocalories per day);
use of hypertension medication; and intakes of alcohol (grams
per week) and fruits, berries, and vegetables (grams per day). All
quantitative variables were entered in the models as continuous
variables. Further adjustment for education years, income, lipid-
lowering medication, or intake of total meat, red meat, processed
red meat, dairy, fiber, trans fatty acids, SFAs, MUFAs, or PUFAs
did not appreciably change the associations (<5% change in
estimates).
The cohort mean was used to replace missing values in
covariates (<2.1% of the values). The significance of interactions
on a multiplicative scale was assessed with the use of a stratified
analysis and likelihood ratio tests with a cross-product term. Tests
of linear trend were conducted by assigning the median values of
each category of exposure variable and treating these as a single
continuous variable. All P values were 2-tailed (α = 0.05). Data
were analyzed with the use of SPSS version 25.0 for Windows
software (IBM Corp.).
Results
The mean ± SD consumption of eggs was 33 ± 26 g/d. The
mean ± SD cholesterol intake was 408 ± 150 mg/d; 114 ± 87
mg/d (27.9%) of cholesterol intake was derived from eggs. Egg
consumption and cholesterol intake had a correlation coefficient
of 0.70 (P value <0.001). A total of 22 participants did not
consume any eggs, and only 3 participants reported consumption
of egg whites instead of whole eggs. About 16% ofmen (n= 306)
consumed ≥1 egg (55 g)/d.
Participants that consumed more eggs were less likely to use
hypertension-lowering medication, have hypertension, or smoke
at baseline (Table 1). They were also more likely to have higher
intakes of energy and SFAs, MUFAs, and dairy and lower intakes
of PUFAs.
Men with higher cholesterol intake had fewer education years
and were less physically active (Table 1). Their concentrations
of serum total and LDL cholesterol were higher and they were
more likely to smoke at baseline. They also had higher intakes of
protein, SFAs, and MUFAs, and lower intakes of carbohydrates,
PUFAs, and fruits, berries, and vegetables.
During the mean± SD follow-up of 21.2± 7.2 y, 217 incident
stroke events occurred, with 166 men diagnosed with ischemic
stroke and 55 men with hemorrhagic stroke. Four men were
diagnosed with both ischemic and hemorrhagic stroke events. We
did not find any statistically significant associations between egg
consumption and risk of total, ischemic, or hemorrhagic stroke
(Table 2). No statistically significant associations were observed
with cholesterol intake, either (Table 3). When evaluated
continuously, each 1 egg/d higher consumption was associated
with an HR of 0.89 (95% CI: 0.64, 1.22) for total stroke, 0.90
(95%CI: 0.62, 1.29) for ischemic stroke, and 0.73 (95%CI: 0.37,
1.44) for hemorrhagic stroke. The HRs of each 100 mg/d higher
cholesterol intake were 0.98 (95% CI: 0.86, 1.12), 0.97 (95% CI:
0.83, 1.13), and 0.94 (95% CI: 0.71, 1.23) for total, ischemic, and
hemorrhagic stroke, respectively.
Egg consumption was not associated with systolic blood
pressure. Among those in the highest egg intake quartile
compared with the lowest, there was a trend toward a 1.6 mm
Hg lower diastolic blood pressure (95% CI: −0.1, 3.3 mm Hg,
P value = 0.09) (P value for trend across the quartiles = 0.04,
model 2, Table 4). Each additional 1 egg/d consumed was
associated with a trend toward a 0.8 mmHg lower diastolic blood
pressure (95%CI:−1.8, 0.1mmHg,P value= 0.09). Cholesterol
intake was not associated with blood pressure (Table 4).
Among the 1015 men with available apoE phenotype data,
287 (28.3%) were carriers of allele 3/4 and 40 (3.9%) of allele
4/4 (Supplemental Table 1). Those with the apoE4 phenotype
were not at increased stroke risk when compared with noncarriers
for total (multivariable-adjusted HR: 0.78; 95% CI: 0.50, 1.20;
29 events among apoE4 carriers and 75 among noncarriers),
ischemic (HR: 0.80; 95% CI: 0.49, 1.30; 23 events among
carriers, 58 among noncarriers), or hemorrhagic stroke (HR:
0.46; 95% CI: 0.17, 1.24; 5 events among carriers, 21 among
noncarriers). There was no statistically significant difference in
the risk of total stroke or ischemic stroke associated with egg
or cholesterol intake between carriers and noncarriers, although
higher cholesterol intake was associated with lower risk of
ischemic stroke among noncarriers (Supplemental Tables 2 and
3). For each 1 egg/d higher consumption, HR for total stroke
was 0.73 (95% CI: 0.24, 2.16) for carriers and 0.58 (95% CI:
0.30, 1.11) for noncarriers of apoE4 (P for interaction = 0.91),
in the multivariable model (model 2). For ischemic stroke,
the respective HRs were 0.73 (95% CI: 0.22, 2.46) and 0.51
(95% CI: 0.24, 1.08) (P for interaction = 0.85). For each
100-mg/d higher cholesterol intake, the HRs for total stroke
were 1.15 (95% CI: 0.79, 1.69) and 0.83 (95% CI: 0.65,
1.06) for apoE4 carriers and noncarriers, respectively (P for
interaction = 0.19), and for ischemic stroke they were 1.13 (95%
CI: 0.73, 1.73) and 0.76 (95% CI: 0.57, 1.01), respectively (P
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TABLE 2 Risk of incident total stroke in 1950 men according to egg consumption at baseline in 1984–19891
Egg consumption in quartiles
1 (<15 g/d) 2 (15–26 g/d) 3 (27–45 g/d) 4 (>45 g/d) P-trend
Participants 487 488 487 488
Total stroke
Events, n (%) 54 (11.1) 56 (11.5) 62 (12.7) 45 (9.2)
Model 12 1 0.95 (0.65, 1.38) 1.05 (0.72, 1.52) 0.77 (0.51, 1.16) 0.23
Model 2 1 1.01 (0.69, 1.47) 1.10 (0.76, 1.61) 0.81 (0.54, 1.23) 0.32
Ischemic stroke
Events, n (%) 40 (8.2) 43 (8.8) 46 (9.5) 37 (7.6)
Model 1 1 0.96 (0.63, 1.49) 1.02 (0.66, 1.57) 0.81 (0.51, 1.30) 0.39
Model 2 1 0.99 (0.64, 1.54) 1.04 (0.67, 1.60) 0.84 (0.53, 1.34) 0.44
Hemorrhagic stroke
Events, n (%) 15 (3.1) 17 (3.5) 14 (2.9) 9 (1.8)
Model 1 1 1.10 (0.55, 2.23) 0.95 (0.45, 2.01) 0.66 (0.28, 1.56) 0.31
Model 2 1 1.29 (0.63, 2.62) 1.09 (0.52, 2.31) 0.75 (0.32, 1.77) 0.40
1Values are HRs (95% CIs) derived by Cox proportional hazards regression models unless otherwise indicated.
2Model 1 was adjusted for age, examination year, and energy intake (kilocalories per day). Model 2 was adjusted as for model 1 plus BMI (kg/m2),
pack-years of smoking, leisure-time physical activity, hypertension medication, and intakes of alcohol and fruit, berries, and vegetables.
for interaction = 0.17). There were too few cases of hemorrhagic
stroke for these stratified analyses. We did not find statistically
significant differences in the associations of egg or cholesterol
intakes with systolic or diastolic blood pressure between carriers
and noncarriers of the apoE4 phenotype, either (Supplemental
Table 4).
To assess whether the associations with stroke incidence were
attenuated by a long follow-up period, we evaluated associations
with events during the first 10 y of follow-up. During this midway
follow-up, there were no statistically significant associations
between egg or cholesterol intake and risk of total stroke (n= 86),
ischemic stroke (n = 62), or hemorrhagic stroke (n = 21) cases,
either. For each 1 egg/d higher consumption, the multivariate-
adjusted HRs were 0.72 (95% CI: 0.41, 1.25) for total stroke,
0.70 (95% CI: 0.36, 1.37) for ischemic stroke, and 0.60 (95%
CI: 0.19, 1.97) for hemorrhagic stroke. For each 100 mg/d higher
cholesterol intake, the multivariate-adjusted HRs were 0.95 (95%
CI: 0.76, 1.18) for total stroke, 0.93 (95% CI: 0.72, 1.21) for
ischemic stroke, and 0.94 (95% CI: 0.60, 1.48) for hemorrhagic
stroke.
Finally, the associations were not appreciably different if
the analyses included only those men with complete data on
all variables (n = 1866 men in the analyses with incident
stroke, n = 1861 in the analyses with blood pressure, and
n = 967 in the analyses with apoE4 phenotype). For example,
the multivariable-adjusted (model 2) HRs were 0.81 (95% CI:
0.53, 1.25) for total stroke, 0.83 (95%CI: 0.51, 1.34) for ischemic
stroke, and 0.75 (95% CI: 0.30, 1.88) for hemorrhagic stroke
in the highest egg consumption quartile compared with the
lowest, and 0.84 (95% CI: 0.54, 1.28) for total stroke, 0.73
(95% CI: 0.44, 1.18) for ischemic stroke, and 1.13 (95% CI:
0.44, 2.87) for hemorrhagic stroke in the highest cholesterol
intake quartile compared with the lowest (other data not
shown).
TABLE 3 Risk of incident total stroke in 1950 men according to cholesterol consumption at baseline in 1984–19891
Cholesterol intake in quartiles
1 (<333 mg/d) 2 (333–387 mg/d) 3 (388–459 mg/d) 4 (>459 mg/d) P-trend
Participants 487 488 488 487
Total stroke
Events, n (%) 47 (9.7) 60 (12.3) 66 (13.5) 44 (9.0)
Model 12 1 1.22 (0.83, 1.79) 1.34 (0.92, 1.96) 0.91 (0.60, 1.34) 0.59
Model 2 1 1.22 (0.83, 1.79) 1.32 (0.90, 1.93) 0.86 (0.57, 1.32) 0.42
Ischemic stroke
Events, n (%) 40 (8.2) 42 (8.6) 53 (10.9) 31 (6.4)
Model 1 1 1.02 (0.66, 1.57) 1.28 (0.85, 1.95) 0.75 (0.47, 1.21) 0.34
Model 2 1 1.04 (0.67, 1.60) 1.28 (0.84, 1.95) 0.74 (0.46, 1.20) 0.32
Hemorrhagic stroke
Events, n (%) 9 (1.8) 19 (3.9) 15 (3.1) 12 (2.5)
Model 1 1 1.88 (0.84, 4.17) 1.43 (0.62, 3.10) 1.24 (0.52, 2.98) 0.99
Model 2 1 1.82 (0.82, 4.05) 1.38 (0.59, 3.22) 1.10 (0.45, 2.66) 0.75
1Values are HRs (95% CIs) derived by Cox proportional hazards regression models unless otherwise indicated.
2Model 1 was adjusted for age, examination year, and energy intake (kilocalories per day). Model 2 was adjusted as for model 1 plus BMI (kg/m2),
pack-years of smoking, leisure-time physical activity, hypertension medication, and intakes of alcohol and fruit, berries, and vegetables.
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Discussion
In this prospective cohort study of middle-aged and older
eastern Finnish men, we did not find statistically significant
associations between egg or cholesterol intake and risk of
incident stroke. In addition, we found no evidence that the
risk would be increased among apoE4 carriers, who are more
susceptible to effects of dietary cholesterol. Furthermore, we did
not find evidence that egg or cholesterol intakes were associated
with elevated blood pressure, a major risk factor for stroke.
Our findings are consistent with most results from previous
research examining egg consumption and stroke risk. Two
meta-analyses from 2013 reported no association between egg
consumption and overall stroke risk (9, 10), although one (9)
reported a 25% lower risk of hemorrhagic stroke associated
with higher egg consumption. An updated meta-analysis with 3
additional cohort studies fromChina (8) and Sweden (25) showed
a slightly reduced risk (9%) in total stroke when consuming ≥1
egg/d (8). Similarly to our study, no associations were found with
either ischemic or hemorrhagic stroke risk in this most recent
meta-analysis. A recent pooled analysis of cohorts from the
United States reported a modest increase in the risk of total stroke
with higher egg intake; however, ischemic and hemorrhagic
stroke were not separately analyzed (4).
The mean amount of egg consumed in the present cohort was
comparable with the consumption in the previous meta-analyses,
and thus probably does not explain the differences in results. An
interesting contrast is observed between egg consumption and
risk of stroke compared with risk of type 2 diabetes. Prospective
studies of egg consumption and risk of type 2 diabetes have
observed an increased risk primarily in studies conducted in
the United States (26–28). This is hypothesized to reflect the
unfavorable lifestyle factors often associated with higher egg
consumption in studies from the United States, including higher
consumption of red meat, smoking, and less physical activity
(26–28). However, in the case of stroke risk, 1 meta-analysis
found an inverse association between egg consumption and stroke
risk mainly in the studies conducted in the United States (7),
although this was not confirmed in the most recent pooled
analysis of 6 studies from the United States (4). More research is
undoubtedly needed to elucidate the impact of egg consumption
on cardiovascular diseases.
In the present study, egg intake was associated with a modestly
lower diastolic blood pressure, but not with systolic blood
pressure. Likewise, observational studies have found higher
egg consumption to be associated with lower blood pressure
(8) and lower risk of hypertension incidence (29, 30). One
randomized crossover intervention reported lack of association
(31), whereas another nonrandomized crossover intervention
reported an inverse association between egg consumption and
diastolic blood pressure (32).
One possible mechanism for this beneficial effect on blood
pressure may be egg white–derived ovotransferrin peptides
that work similarly to antihypertensive medication, preventing
vascular smooth muscle remodeling via inhibition of angiotensin
type 1 receptors (33). Another explanation could be attributed
to phospholipids found in egg yolk that have been associated
with enhanced endothelial vasodilatory function (34). A third
explanation may relate to antioxidants in egg, which could ame-
liorate oxidative stress and vascular function and consequently
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reduce blood pressure (35). The evidence is still inconclusive,
and more research is necessary to explicate the association of egg
consumption with blood pressure and, therefore, stroke risk (7–
9).
We did not find associations between cholesterol intake
and stroke risk, a finding that corroborates most previous
studies. For example, 2 meta-analyses indicated no statistically
significant associations between cholesterol intake and ischemic
or hemorrhagic stroke risk (5, 6). On the other hand, another
recently published pooled analysis found cholesterol intake to
be associated with higher total stroke risk (4). In addition,
a few observational studies have found higher cholesterol
intake to be associated with higher systolic blood pressure
(12, 13), an observation that we did not find. Owing to the
scarce epidemiological and experimental evidence, the role of
dietary cholesterol in blood pressure regulation remains largely
uncertain.
To our knowledge, no other study has investigated the relation
of egg consumption with stroke risk among those more sensitive
to dietary cholesterol intake, i.e., apoE4 carriers. Our results
showed no evidence that egg or cholesterol intakes would be
associated with higher stroke risk or with high blood pressure
among apoE4 carriers. These findings are in accordance with our
previous observations in this study population, where we found
that higher egg or cholesterol intakes were not associated with
risk of CAD, carotid atherosclerosis, or hypercholesterolemia
among apoE4 carriers (19).
Strengths of this study include the prospective design, very
little loss to follow-up, and information on several potential
confounders. Limitations of the study include the inherent bias
and random error associated with dietary assessment methods;
also, the dietary intakes, being assessed only at baseline, may
not reflect accurate or long-term intake. Even though these
limitations provide opportunity for misclassification that can
potentially attenuate associations in analyses with long follow-
up periods, the similar results we observed in the midway 10-
y follow-up corroborate our findings. Furthermore, the average
egg consumption in Finland has been fairly consistent over
the past 40 y (36). Although egg intakes in mixed dishes and
baked goods were collected, different preparation methods not
accounted for could influence associations with stroke risk. In
addition, there may also be residual confounding by unmeasured
or incompletely measured factors that may have influenced the
findings. The median intakes in the highest quartile were 61
g/d for egg and 523 mg/d for cholesterol, therefore our results
may not be applicable to populations with higher intakes. The
variability in egg consumption might have been too low to
observe significant associations. However, we have previously
reported that egg consumption was associated with lower fasting
plasma glucose and serum C-reactive protein and with lower
risk of type 2 diabetes (37) and with better performance on
neuropsychological tests (38) in this study population, suggesting
sufficient variability for finding associations also with stroke risk.
The number of hemorrhagic stroke events was low, so these
results should be interpreted with caution. Similarly, the data
on the apoE phenotype were available only for a part of the
study population, so the findings may not represent the whole
study population. The associations between egg and cholesterol
intakes and blood pressure were cross-sectional and therefore by
design do not infer temporal associations. Because this study only
consisted of middle-aged and older men from eastern Finland, the
results cannot be extrapolated to women or other ethnicities.
In conclusion, neither egg nor cholesterol intakes were
associated with stroke risk in this cohort, regardless of apoE
phenotype.
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